Literature DB >> 26588234

Endometrial Cancer Survivors' Perceptions of Provider Obesity Counseling and Attempted Behavior Change: Are We Seizing the Moment?

Leslie H Clark1, Emily M Ko, Amber Kernodle, Ariel Harris, Dominic T Moore, Paola A Gehrig, Victoria Bae-Jump.   

Abstract

OBJECTIVE: To determine patients' perceptions of provider-based counseling and behavior changes made by endometrial cancer survivors.
MATERIALS AND METHODS: Endometrial cancer survivors (diagnosed from 2011 to 2012) from a single institution were surveyed. Exclusion criteria included persistent or recurrent disease or those actively undergoing treatment. Information collected included demographics, weight assessments, health behaviors, and physician counseling. Statistical analysis was performed using descriptive statistics, Fisher exact test, McNemar test, and the κ statistic as a measure of agreement.
RESULTS: Of 233 surveys sent, 46% were returned. Median body mass index was 29.8 kg/m (range, 17.1-64.8 kg/m). Comparing primary care providers with gynecologic oncologists (GOs), 47% (n = 46) versus 25% (n = 23) provided dietary counseling and 62% (n = 60) versus 37% (n = 34) provided physical activity counseling (Fisher exact test, P = 0.001 and P < 0.001, respectively). Only 29% (n = 30) reported being told of the link between endometrial cancer and obesity. Fifty-two percent of responders attempted weight loss after their diagnosis. Fifty-nine percent of responders reported making changes in their diet. Fifty-six percent of patients made dietary changes within 3 months of diagnosis. Forty-eight percent of responders increased physical activity, with 62% implementing changes within 3 to 6 months of their diagnosis. The responders most likely to attempt weight loss were those who received counseling by a provider. All patients reporting attempted weight loss after their cancer diagnosis report being counseled by either a primary care provider or a GO to lose weight. Weight loss counseling was significantly associated with attempting weight loss (P < 0.001).
CONCLUSIONS: One third of endometrial cancer survivors report counseling by their GO to lose weight. One half of endometrial cancer survivors reported attempted weight loss. All patients reporting weight loss counseling from their oncologist reported attempted weight loss. Most behavioral change occurred 3 to 6 months after a cancer diagnosis. Obesity in endometrial cancer survivors is not adequately addressed and represents a critical area for improvement.

Entities:  

Mesh:

Year:  2016        PMID: 26588234     DOI: 10.1097/IGC.0000000000000596

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  11 in total

1.  Agenda for Translating Physical Activity, Nutrition, and Weight Management Interventions for Cancer Survivors into Clinical and Community Practice.

Authors:  Karen Basen-Engquist; Catherine M Alfano; Melissa Maitin-Shepard; Cynthia A Thomson; Kathryn H Schmitz; Bernardine M Pinto; Kevin Stein; David S Zucker; Karen L Syrjala; Elizabeth Fallon; Colleen Doyle; Wendy Demark-Wahnefried
Journal:  Obesity (Silver Spring)       Date:  2017-11       Impact factor: 5.002

Review 2.  Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.

Authors:  Michaela A Onstad; Rosemarie E Schmandt; Karen H Lu
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

3.  Perceptions of weight management counseling among gynecologic cancer survivors: opportunities for enhancing survivorship care.

Authors:  Alexandra K Zaleta; Robert Neff; Georgia A McCann; David M O'Malley; Kristen M Carpenter
Journal:  Support Care Cancer       Date:  2017-01-03       Impact factor: 3.603

4.  Cancer-related psychosocial factors and self-reported changes in lifestyle among gynecological cancer survivors: cross-sectional analysis of PROFILES registry data.

Authors:  Karin A J Driessen; Belle H de Rooij; M Caroline Vos; Dorry Boll; Johanna M A Pijnenborg; Meeke Hoedjes; Sandra Beijer; Nicole P M Ezendam
Journal:  Support Care Cancer       Date:  2021-08-28       Impact factor: 3.359

5.  Perceived barriers and preferred components for physical activity interventions in African-American survivors of breast or endometrial cancer with type 2 diabetes: the S.U.C.C.E.S.S. framework.

Authors:  Kristin Z Black; La-Shell Johnson; Carmen D Samuel-Hodge; Lavanya Gupta; Aditi Sundaresan; Wanda K Nicholson
Journal:  Support Care Cancer       Date:  2017-08-01       Impact factor: 3.603

6.  Barriers to care for women with low-grade endometrial cancer and morbid obesity: a qualitative study.

Authors:  Maria C Cusimano; Andrea N Simpson; Angela Han; Robin Hayeems; Marcus Q Bernardini; Deborah Robertson; Sari L Kives; Abheha Satkunaratnam; Nancy N Baxter; Sarah E Ferguson
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

7.  Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: A qualitative study.

Authors:  Montana O'Hara; Monika Janda; Alexandra L McCarthy; James Nicklin; Graeme Walker; Andreas Obermair
Journal:  Gynecol Oncol Rep       Date:  2021-12-22

Review 8.  Association of Healthy Diet and Physical Activity With Breast Cancer: Lifestyle Interventions and Oncology Education.

Authors:  Tiantian Jia; Yufeng Liu; Yuanyuan Fan; Lintao Wang; Enshe Jiang
Journal:  Front Public Health       Date:  2022-03-23

9.  Use of intervention mapping to adapt a health behavior change intervention for endometrial cancer survivors: the shape-up following cancer treatment program.

Authors:  Dimitrios A Koutoukidis; Sonia Lopes; Lou Atkins; Helen Croker; M Tish Knobf; Anne Lanceley; Rebecca J Beeken
Journal:  BMC Public Health       Date:  2018-03-27       Impact factor: 3.295

10.  Patient-initiated follow-up of early endometrial cancer: a potential to improve post-treatment cardiovascular risk?

Authors:  Racheal Louise Johnson; Cheng Choy
Journal:  Arch Gynecol Obstet       Date:  2021-08-07       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.